• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转染的II型白细胞介素-1受体损害人角质形成细胞对白介素-1的反应性。

Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1.

作者信息

Bossù P, Visconti U, Ruggiero P, Macchia G, Muda M, Bertini R, Bizzarri C, Colagrande A, Sabbatini V, Maurizi G

机构信息

Research Center Dompé SpA, L'Aquila, Italy.

出版信息

Am J Pathol. 1995 Dec;147(6):1852-61.

PMID:7495308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1869949/
Abstract

Of the two known types of specific receptors for interleukin (IL)-1, the function of the type II IL-1 receptor (IL-1RII) is still elusive. IL-1RII is allegedly devoid of signaling capacity and is therefore thought to act by trapping and inhibiting IL-1. To directly assess the functional role of IL-1RII, a human keratinocyte cell line has been stably transfected with a cDNA coding for IL-1RII, and its responsiveness to IL-1 has been compared with that of nontransfected cells. Parental cells express IL-1RI and are responsive to low doses of IL-1, whereas transfected cells overexpress IL-1RII, both in its membrane and soluble form, and show a dramatically impaired response to IL-1. Selective block of IL-1RII restores the ability of transfected keratinocytes to respond to IL-1, indicating that the overexpressed IL-1RII is in fact uniquely responsible for their refractoriness to IL-1. The main mechanism of unresponsiveness in transfected keratinocytes appears to be the capture and neutralization of IL-1 by the soluble form of IL-1RII.

摘要

在白细胞介素(IL)-1的两种已知特异性受体类型中,II型IL-1受体(IL-1RII)的功能仍不清楚。据称IL-1RII缺乏信号传导能力,因此被认为通过捕获和抑制IL-1发挥作用。为了直接评估IL-1RII的功能作用,用人角质形成细胞系稳定转染编码IL-1RII的cDNA,并将其对IL-1的反应性与未转染细胞进行比较。亲代细胞表达IL-1RI,对低剂量IL-1有反应,而转染细胞在膜和可溶性形式上均过度表达IL-1RII,并对IL-1的反应显著受损。选择性阻断IL-1RII可恢复转染角质形成细胞对IL-1的反应能力,表明过度表达的IL-1RII实际上是其对IL-1难治性的唯一原因。转染角质形成细胞无反应的主要机制似乎是可溶性形式的IL-1RII捕获和中和IL-1。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8475/1869949/135e315ef7d0/amjpathol00048-0339-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8475/1869949/135e315ef7d0/amjpathol00048-0339-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8475/1869949/135e315ef7d0/amjpathol00048-0339-a.jpg

相似文献

1
Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1.转染的II型白细胞介素-1受体损害人角质形成细胞对白介素-1的反应性。
Am J Pathol. 1995 Dec;147(6):1852-61.
2
The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.II型白细胞介素-1受体与白细胞介素-1受体辅助蛋白相互作用:白细胞介素-1反应性调节的新机制。
J Immunol. 1998 Dec 15;161(12):6871-7.
3
Interleukin-1 receptors type I and type II are differentially regulated in human keratinocytes by ultraviolet B radiation.紫外线B辐射对人角质形成细胞中I型和II型白细胞介素-1受体的调控存在差异。
J Invest Dermatol. 1996 Dec;107(6):865-70.
4
Molecular characterization and functional expression of equine interleukin-1 type I and type II receptor cDNAs.马I型和II型白细胞介素-1受体cDNA的分子特征及功能表达
Vet Immunol Immunopathol. 2006 Feb 15;109(3-4):219-31. doi: 10.1016/j.vetimm.2005.08.018. Epub 2005 Sep 19.
5
The membrane form of the type II IL-1 receptor accounts for inhibitory function.II型白细胞介素-1受体的膜形式具有抑制功能。
J Immunol. 2000 Sep 15;165(6):3350-7. doi: 10.4049/jimmunol.165.6.3350.
6
The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis.白细胞介素-1的II型诱饵受体可抑制小鼠胶原诱导的关节炎。
Eur J Immunol. 2000 Mar;30(3):867-75. doi: 10.1002/1521-4141(200003)30:3<867::AID-IMMU867>3.0.CO;2-M.
7
Synthesis of type II interleukin-1 receptors by human corneal epithelial cells but not by keratocytes.人角膜上皮细胞可合成II型白细胞介素-1受体,而角膜细胞则不能。
Invest Ophthalmol Vis Sci. 2001 Mar;42(3):701-4.
8
Selectivity release of the type II decoy IL-1 receptor.II型诱饵白细胞介素-1受体的选择性释放
Cytokine. 2000 Jul;12(7):1001-6. doi: 10.1006/cyto.1999.0601.
9
Molecular characterization of the bovine type II IL-1 receptor.牛II型白细胞介素-1受体的分子特征
Cytokine. 1997 Jan;9(1):1-8. doi: 10.1006/cyto.1996.0129.
10
Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA.一种经过可变剪接的人II型白细胞介素-1受体mRNA的克隆与特性分析
J Biol Chem. 1996 Aug 23;271(34):20965-72. doi: 10.1074/jbc.271.34.20965.

引用本文的文献

1
Differences of IL-1β Receptors Expression by Immunocompetent Cells Subsets in Rheumatoid Arthritis.类风湿关节炎中免疫活性细胞亚群的白细胞介素-1β受体表达差异
Mediators Inflamm. 2015;2015:948393. doi: 10.1155/2015/948393. Epub 2015 Sep 10.
2
Aberrantly Expressed Genes in HaCaT Keratinocytes Chronically Exposed to Arsenic Trioxide.长期暴露于三氧化二砷的HaCaT角质形成细胞中异常表达的基因
Biomark Insights. 2011 Feb 8;6:7-16. doi: 10.4137/BMI.S6383.
3
Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.

本文引用的文献

1
Keratinocytes: key immunocytes of the integument.角质形成细胞:皮肤的关键免疫细胞。
Am J Pathol. 1993 Aug;143(2):325-31.
2
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.白细胞介素-1Ⅱ型受体:一种受白细胞介素-4调节的白细胞介素-1诱饵靶点。
Science. 1993 Jul 23;261(5120):472-5. doi: 10.1126/science.8332913.
3
Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.脓毒症中可溶性II型白细胞介素-1受体水平升高。II型受体在白细胞介素-1反应调节中的潜在作用。
采用 XOMA 052 进行途径衰减的动力学方法,XOMA 052 是一种调节白介素-1β活性的调节性治疗抗体。
J Biol Chem. 2010 Jul 2;285(27):20607-14. doi: 10.1074/jbc.M110.115790. Epub 2010 Apr 21.
4
Role of IL-1 beta and 5-HT2 receptors in midbrain periaqueductal gray (PAG) in potentiating defensive rage behavior in cat.白细胞介素-1β和5-羟色胺2型受体在猫中脑导水管周围灰质增强防御性愤怒行为中的作用
Brain Behav Immun. 2008 Feb;22(2):224-33. doi: 10.1016/j.bbi.2007.07.011. Epub 2007 Sep 24.
5
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment.白细胞介素-1与癌症进展:白细胞介素-1受体拮抗剂作为癌症治疗新疗法的新兴作用。
J Transl Med. 2006 Nov 10;4:48. doi: 10.1186/1479-5876-4-48.
6
Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria.通过产芽孢重组细菌进行抗炎性白细胞介素-1受体拮抗剂的黏膜递送。
BMC Biotechnol. 2004 Oct 30;4:27. doi: 10.1186/1472-6750-4-27.
7
In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.由戈登链球菌产生的生物活性人白细胞介素1受体拮抗剂的体内黏膜递送
BMC Biotechnol. 2003 Sep 17;3:15. doi: 10.1186/1472-6750-3-15.
8
Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis.人子宫内膜异位症中诱饵型白细胞介素-1受体II型表达降低。
Am J Pathol. 2001 Feb;158(2):481-9. doi: 10.1016/S0002-9440(10)63990-9.
J Immunol. 1994 Dec 15;153(12):5802-9.
4
Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis.人表皮中白细胞介素-1受体的检测。器官培养后及银屑病中II型受体的诱导。
Am J Pathol. 1994 Nov;145(5):1048-56.
5
Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.可溶性白细胞介素-1受体与白细胞介素-1α、白细胞介素-1β及白细胞介素-1受体拮抗剂的结合以及滑液中可溶性白细胞介素-1受体的水平
J Immunol. 1994 Nov 15;153(10):4766-74.
6
The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.II型“诱饵”受体:白细胞介素1的一种新型调节途径。
Immunol Today. 1994 Dec;15(12):562-6. doi: 10.1016/0167-5699(94)90217-8.
7
Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implications for IL-1-mediated processes in epidermis.培养的人角质形成细胞对2型白细胞介素-1受体的诱导性表达。对表皮中白细胞介素-1介导过程的影响。
J Immunol. 1995 Apr 15;154(8):4065-72.
8
Single-cell analysis of macrophage chemotactic protein-1-regulated cytosolic Ca2+ increase in human adherent monocytes.人贴壁单核细胞中巨噬细胞趋化蛋白-1调节的胞质Ca2+增加的单细胞分析
Blood. 1995 Sep 15;86(6):2388-94.
9
Effect of ultraviolet radiation on production of epidermal cell thymocyte-activating factor/interleukin 1 in vivo and in vitro.紫外线辐射对体内和体外表皮细胞胸腺细胞激活因子/白细胞介素1产生的影响。
Proc Natl Acad Sci U S A. 1984 Feb;81(4):1198-202. doi: 10.1073/pnas.81.4.1198.
10
Ligand: a versatile computerized approach for characterization of ligand-binding systems.配体:一种用于表征配体结合系统的通用计算机化方法。
Anal Biochem. 1980 Sep 1;107(1):220-39. doi: 10.1016/0003-2697(80)90515-1.